Replay available

Molecular Partners AG (MOLN) Q4 2023 Earnings Call

Molecular Partners AG (NASDAQ: MOLN) Q4 2023 earnings conference call, held 2024-03-15. Replay captured from the company's public earnings webcast.

Fri, March 15, 2024 at 8:00 AMendedReplay
Molecular Partners AG (MOLN) Q4 2023 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Seth Lewis

Senior Vice President, Investor Relations

Patrick Amstlich

Chief Executive Officer

Robert Hendricks

Senior Vice President of Finance

Philippe Lejeune

Acting Chief Medical Officer

Anne Goubier

Senior Vice President of Research and Early Development

Danny Steiner

Senior Vice President of Research and Technology

Richard Vosser

Analyst, J.P. Morgan

Mike Medelkovich

Analyst, TD Cowen

Kathleen Silverman

Analyst, WeRank

Flora Zinnerman

Analyst, Octavian Capital

Replay transcript excerpt

Good day and welcome to the Molecular Partners fourth quarter and full year 2023 results conference call. All participants will be in a listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star, then one on a touch-tone phone. To withdraw your question, please press star, then two. Please note this event is being recorded. I would now like to turn the conference over to Seth Lewis, Senior Vice President, Investor Relations. Please go ahead. Thank you, Betsy. And welcome, everybody. Good morning and good afternoon to the 2023 full-year earnings call for Molecular Partners. My name is Seth Lewis, Senior Vice President of Investor Relations. I wanted to just go over a little bit of housekeeping before we began. Obviously, we are speaking today in reference to the press release, which was issued after the close of market yesterday, as well as the full year annual results, which are in the annual report, which can be found on our website, molecularpartners.com. And we'll be making reference and prepared remarks today to the presentation, which slides are also available under the investor section of our website, molecularpartners.com. If you are following along in the presentation, I will refer to you, we are going to make certain forward-looking statements today, and I would refer you to our latest filings and most recent filings with the SEC and with the SICs. For the sake of the replay today, we are recording this on March 15th, 2023. If you were on slide three, I just wanted to take you through the agenda briefly. We are joined today by multiple members of our management team, including Pat...

More from Molecular Partners Ag